Public Hearings

Past Public Hearings and Transcripts

DateLocationTranscriptProgramSubmissions
03 Sep 2020Canberra, ACT(HTML & PDF)PDF: Canberra 1 (3/09/2020) 29495None
05 Feb 2021Canberra, ACT(HTML & PDF)PDF: Canberra 2 (5/02/2021) 29771None
11 Mar 2021Sydney, NSW(HTML & PDF)PDF: Sydney 1 (11/03/2021) 29848None
12 Mar 2021Sydney, NSW(HTML & PDF)PDF: Sydney 2 (12/03/2021) 29849None
26 Mar 2021Canberra, ACT(HTML & PDF)PDF: Canberra 3 (26/03/2021) 29867None
22 Apr 2021Melbourne, VIC(HTML & PDF)PDF: Melbourne 1 (22/04/2021) 29876None
23 Apr 2021Melbourne, VIC(HTML & PDF)PDF: Melbourne 2 (23/04/2021) 29877None
07 May 2021Sydney, NSW(HTML & PDF)PDF: Sydney 3 (7/05/2021) 29927None
17 May 2021Brisbane, QLD(HTML & PDF)PDF: Brisbane 1 (17/05/2021) 29928None
18 May 2021Brisbane, QLD(HTML & PDF)PDF: Brisbane 2 (18/05/2021) 29929None
18 Jun 2021Canberra, ACT(HTML & PDF)PDF: Canberra 4 (18/06/2021) 30008None
24 Jun 2021Canberra, ACT(HTML & PDF)PDF: Canberra 5 (24/06/2021) 30009None
07 Jul 2021Canberra, ACT(HTML & PDF)PDF: Canberra (7/07/2021) 30048None

About this inquiry

Following a referral on 13 August 2020 from the Minister for Health, The Hon Greg Hunt MP, the Committee will inquire into and report on approval processes for new drugs and novel medical technologies in Australia.



Inquiry Status

Submissions Closed

Accessibility

We are committed to ensuring that everyone who wishes to can participate in the Committee’s inquiry. If you have accessibility requirements, please contact the Committee Secretariat.

Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility